Results 71 to 80 of about 919 (150)
Медицинский совет, 2017 Relevance: According to the literature, Vulvovaginal candidiasis (VVC) is diagnosed in 75% of women during life, and in 5-8% of women its recurrent course is developed (four or more episodes of exacerbation during 12 months).
S. M. Pogosyan +5 more
doaj +1 more source
Therapeutic approaches in the treatment of vulvovaginal candidiasis
Медицинский совет, 2020 According to world statistics, vulvovaginal candidiasis is a very common disease with a serious tendency to recurrence and chronic-ity, which makes it a fundamentally significant medical and social problem, the solution of which is becoming a priority ...
A. Z. Khashukoeva +4 more
doaj +1 more source
Case Reports in Dermatological Medicine, Volume 2026, Issue 1, 2026.First described in 1994, fixed drug eruption (FDE) to fluconazole is uncommon but possibly underdiagnosed. Of these, women with vaginal candidiasis remain the most affected, with on average more than four occurrences prior to diagnosis. We present a case of a 29‐year‐old female who presented after her third episode of an itchy, oedematous, blistering ...
D. S. Sron +5 more
wiley +1 more source
Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis
, 2015 OBJECTIVE: To evaluate associations between polymorphisms in the gene coding for mannose-binding lectin (MBL) and the diagnosis of acute or recurrent vulvovaginal candidiasis and bacterial vaginosis METHODS: Women at two outpatient clinics in Brazil ...
Giraldo, PC +6 more
core +1 more source
Dermatologic Therapy, Volume 2026, Issue 1, 2026.Objective To evaluate adverse events (AEs) associated with Bimekizumab through data mining of the U.S. Food and Drug Administration’s Adverse Event Reporting System (FAERS), aiming to explore potential drug‐related AEs and provide guidance for clinical medication safety.
Junxia Cao, Na Yang, Suraiya Saleem
wiley +1 more source
Treatment for recurrent vulvovaginal candidiasis (thrush) (Protocol)
, 2011 This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective of this systematic review is to assess the relative efficacy of pharmacological and non-pharmacological treatments for recurrent vulvovaginal
Cathy Watson +9 more
core +1 more source
The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis [PDF]
Гинекология, 2017 Host immunity against Candida albicans is crucial in controlling C. albicans infection. The innate immunity is believed to be the first line of host defense, such as the direct killing of yeasts through phagocytosis by neutrophils and macrophages.
Sh M Pogosyan +4 more
doaj
Health Benefits and Therapeutic Potential of Quercetin
Journal of Food Biochemistry, Volume 2026, Issue 1, 2026.Quercetin, a polyphenolic compound prevalent in many fruits, vegetables, and other dietary sources, has attracted considerable interest due to its extensive health benefits. This review examines its diverse biological properties, particularly its antioxidant and anti‐inflammatory effects. The study integrates recent scientific findings to elucidate the
Mahendra Aryal, Kim Wei Chan
wiley +1 more source
Drug Design, Development and Therapy, 2023 Nancy A Phillips, Maria Rocktashel, Lena Merjanian Department Obstetrics, Gynecology & Reproductive Sciences, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USACorrespondence: Nancy A Phillips, Department Obstetrics, Gynecology ...
Phillips NA, Rocktashel M, Merjanian L
doaj
New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges.
Frontiers in Microbiology, 2012 The commensal fungus Candida albicans causes mucosal candidiasis in the rapidly expanding number of immunocompromised patients. Mucosal candidiasis includes orapharyngeal, esophageal, gastrointestinal, and vaginal infections.
Anna eVecchiarelli +3 more
doaj +1 more source